Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Signal, Speculation, and Standards of Proof in Iatrogenic Alzheimer Disease.

JAMA neurology·2026

Same author

Genetic Creutzfeldt-Jakob disease linked to the E200K mutation: a large cohort study.

Acta neuropathologica·2026

Same author

Recovery and Discharge Disposition After Retrosigmoid Versus Translabyrinthine Approaches for Vestibular Schwannoma Resection: A Retrospective Review of 301 Patients.

Neurosurgery·2025

Same author

Structural exposure of different microtubule binding domains determines the propagation and toxicity of pathogenic tau conformers in Alzheimer's disease.

PLoS pathogens·2025

Same author

Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival.

Frontiers in cellular neuroscience·2025

Same author

Characterization of variably protease-sensitive prionopathy by capillary electrophoresis.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: Mar 1, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Pathology of cavernous malformations.

Efrem M Cox¹, Nicholas C Bambakidis¹, Mark L Cohen²

¹Department of Neurosurgery, University Hospitals, Case Western Reserve University, Cleveland, OH, USA.

Handbook of Clinical Neurology

|May 30, 2017

Summary

Cavernous malformations (CMs) are vascular lesions that can form newly or be inherited. Understanding their abnormal vascular pathology and genetic basis (CCM1-3) is key to preventing hemorrhage.

Keywords:

angiogenesis cavernous malformation epilepsy pathophysiology ultrastructural analysis

More Related Videos

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Related Experiment Videos

Last Updated: Mar 1, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Area of Science:

Vascular biology
Medical pathology
Genetics

Background:

Cavernous malformations (CMs) are vascular lesions characterized by abnormal blood-filled caverns.
While once thought congenital, evidence supports de novo CM formation, occurring sporadically or inherited.
Pathophysiology involves abnormal angiogenesis and compromised endothelial cell integrity, linked to CCM1, CCM2, and CCM3 genes.

Purpose of the Study:

To elucidate the pathophysiology of cavernous malformations.
To explore the genetic underpinnings (CCM1-3) of CM development and hemorrhage.
To analyze the role of growth factors in CM lesion behavior.

Main Methods:

Review of gross and microscopic pathological findings.
Ultrastructural analysis of endothelial cell aberrations.
Examination of genetic factors (CCM1, CCM2, CCM3) involved in vascular pathology.

Main Results:

Abnormal vascular pathology and angiogenesis are central to CM development.
Genetic mutations in CCM1, CCM2, and CCM3 compromise vessel integrity.
Ultrastructural analysis reveals endothelial cell aberrations contributing to hemorrhage propensity.

Conclusions:

Cavernous malformations arise from complex vascular pathology, influenced by genetic factors.
Understanding endothelial cell structural integrity is crucial for CM hemorrhage risk assessment.
Further research into growth factors may offer insights into CM lesion dynamics.